Pipeline Café 2017

The Pipeline Café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.

2017 Pipeline Cafe Participants:

A platform for developing drug and cell-based therapeutics targeting fat metabolism for treatment of obesity and metabolic disease
Brian Gillette, PhD, Co-Founder, Director, Ardent Cell Technologies

Enhancing the Immune System during Cancer Therapy
Cynthia L. Bristow, PhD, Chief Executive Officer, Alpha-1 Biologics

Fighting blindness with polymeric nanotechnology for ocular biologics delivery
Brian W. Pan, CEO, BioHealthWays, Inc.

Therapeutic development of miR-129 mimic for metastatic colorectal cancer
Jingfang Ju, PhD, Founder, CurMiR; Professor, Pathology, Stony Brook University

The development of a rapid and highly-efficiency platform for isolating human antibodies to treat infectious diseases
Raymond A. Alvarez, PhD, Co-founder & CEO, Ichor Biologics

Non-Invasive In Vivo Optical Detection of Lipid Accumulation for NAFLD Drug Discovery
Prakrit V. Jena, PhD, CEO, LipidSense

Novel bacteria-based immunotherapeutic strategies for the treatment of cancer
Boris Shor, PhD, Founder & CEO, Manhattan BioSolutions

MouSensor: Super sniffer mice to digitize the sense of smell 
Charlotte D’Hulst, PhD, Co-Founder & Yukie Takabatake, PhD, Scientist, MouSensor, LLC

Development of Targeted Delivery of β-Catenin Agonists for Non-union Fracture Healing
Seth Harlem, CEO, Taithera, Inc.

Widening The Therapeutic Window: Time-dependent Inhibitors of LpxC For Treating MDR Gram Negative Bacterial Infections 
Peter Tonge, PhD, CSO, Chronus Pharmaceuticals; Director, Infectious Disease Research, Institute for Chemical Biology and Drug Discovery & Fereidoon Daryaee, PhD, Postdoctoral Associate, Chemistry, Stony Brook University

a Novel PET Radiotracer for Imaging Bacterial Infection
Peter Tonge, PhD, CSO, Chronus Pharmaceuticals; Director, Infectious Disease Research, Institute for Chemical Biology and Drug Discovery & Yong Li, PhD Candidate, Chemistry, Stony Brook University

View our 2016 Pipeline Cafe participants